CQN-MN-DATASITE
Second paragraph, second sentence of release should read: The company’s due diligence application, formerly known as DatsiteOne Diligence, is now Datasite Diligence™, and its application for optimizing the early stage asset marketing process, formerly known as DatasiteOne Marketing, is now Datasite Outreach™ (instead of The company’s due diligence application, formerly known as DatsiteOne Diligence, is now Datasite® Diligence, and its application for optimizing the early stage asset marketing process, formerly known as DatasiteOne Marketing, is now Datasite® Outreach).
The corrected release reads:
MERRILL CORPORATION ANNOUNCES REBRAND TO DATASITE
New name reflects the company’s transformation and focus on using technology to drive success across the entire M&A lifecycle
Merrill Corporation, the leading technology provider for global mergers and acquisitions (M&A) professionals, today announced its corporate rebrand to Datasite. The new brand identity was created to better reflect the completion of the company’s 2018 digital transformation, which included divesting its legacy financial printing business, to focus on its global, SaaS-based technology platform for the M&A community.
In addition to a fresh company name, logo, and website, Datasite has also updated the branding of its core applications. The company’s due diligence application, formerly known as DatsiteOne Diligence, is now Datasite Diligence™, and its application for optimizing the early stage asset marketing process, formerly known as DatasiteOne Marketing, is now Datasite Outreach™.
“This is a major milestone in our company’s history,” said Rusty Wiley, CEO of Datasite. “We’ve evolved into an agile, global fintech software company and the Datasite name better represents our mission to lead the M&A industry beyond the virtual data room to a digitally-enabled future across the entire M&A lifecycle.”
In 2019, Datasite’s revenue increased by more than 30% as it facilitated more than 10,000 deals annually. To accommodate this growth, the company has moved its global headquarters from St. Paul, where it has been for 52 years, to the Baker Center in downtown Minneapolis, continuing its longstanding investment in the Twin Cities.
“As we continue to scale for growth, our commitment to the Twin Cities remains unchanged,” said Wiley. “We’re proud to have our global headquarters in Minneapolis and look forward to drawing from the area’s talented and diverse workforce.”
The new space can accommodate over 450 employees and is expected to bring additional jobs across finance, technology, and service to the region. Datasite currently employs more than 750 individuals in 25 locations across 13 countries.
At 80,000 square feet, the new headquarters replaces the St. Paul and North Loop offices, bringing together Datasite’s sales, service, product, marketing, finance, legal, IT and HR teams – the highest number of employees operating under one roof in the company’s history. The integrated design for the headquarters was modeled after the success of Datasite’s New York, London and Hong Kong locations.
To learn more about Datasite’s history and new global corporate headquarters, please visit: www.datasite.com
About Datasite
Datasite, formerly known as Merrill Corporation, is a leading SaaS provider for the M&A industry, empowering dealmakers around the world with the tools they need to succeed across the entire deal lifecycle. For more information, visit www.datasite.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200324005006/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 16:09:00 CEST | Press release
ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 16:00:00 CEST | Press release
With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2%Global Phase 3 MANEUVER study demonstrated ongoing improvements in key secondary endpoints including pain and functionApplication for marketing authorization under review by China National Medical Products Administration (NMPA), with additional applications planned in the U.S. and other marketsNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the stud
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week17.10.2025 15:04:00 CEST | Press release
- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year - - Second pivotal development program of povetacicept underway with Phase 2b/3 trial initiation in primary membranous nephropathy - - Updated data from RUBY-3 trial of povetacicept accepted for late breaking oral presentation; inaxaplin study design and APOL1-mediated kidney disease related data accepted for poster presentation - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B c
Qualcomm Announces Quarterly Cash Dividend17.10.2025 15:00:00 CEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing
Illumynt Reports Q3 2025 Business Update17.10.2025 14:39:00 CEST | Press release
Q3 2025 was a busy quarter once again for us here at illumynt. In addition to naming a new CEO, we executed on a number of initiatives that are propelling our organization forward. Revenue for the quarter exceeded $30 million- keeping us on track for our 2025 plan. More importantly we executed three different large-scale data center decommission projects with almost no material ending up as scrap. All of the AI-focused enterprise equipment and components recovered from the decommissions were resold at top market value. We head into Q4 with high expectations and our eyes wide open. We’re celebrating the 20-year anniversary of our facility in Hong Kong and looking to add another location in the region to help us process inbound AI data center equipment. Stay tuned for updates. There will be more on the way. View source version on businesswire.com: https://www.businesswire.com/news/home/20251017446548/en/
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom